Uranium-chelating peptides derived from EF-hand calcium-binding motif useful for uranium biodetection and biodecontamination

US9845343B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9845343-B2
Application numberUS-201414779114-A
CountryUS
Kind codeB2
Filing dateMar 28, 2014
Priority dateMar 28, 2013
Publication dateDec 19, 2017
Grant dateDec 19, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Uranium-chelating polypeptides comprising at least one helix-loop-helix calcium-binding (EF-hand) motif which comprises a deletion of at least two amino acid in the 12-amino-acid calcium-binding loop sequence, and their use for uranium biodetection and biodecontamination.

First claim

Opening claim text (preview).

The invention claimed is: 1. A polypeptide comprising at least one helix-loop-helix calcium-binding (EF-hand) motif with deletion of two amino acid residues in the 12-amino-acid calcium-binding loop sequence selected from the group consisting of deletion in positions 1 and 2, and deletion in positions 2 and 3, wherein said polypeptide binds uranyl. 2. The polypeptide of claim 1 , wherein said EF-hand motif(s) are derived from signaling EF-hand protein(s) of the calmodulin superfamily selected from the group consisting of calmodulin and troponin C. 3. The polypeptide of claim 1 , which comprises two or four EF-hand motifs, wherein at least one EF-hand motif comprises said deletion in the calcium-binding loop sequence, and the other EF-hand motif(s) comprise said deletion or not. 4. The polypeptide of claim 2 , which is a calmodulin domain 1 variant comprising two EF-hand motifs, respectively from the EF-hand 1 and the EF-hand2 of calmodulin protein(s). 5. The polypeptide of claim 3 , which comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 17, 18, 20 and 60. 6. A fusion protein comprising a polypeptide according to claim 1 fused to another protein moiety. 7. The fusion protein of claim 6 , which is a cameleon protein comprising tandem fusions of a fluorescence-donor protein, a polypeptide which comprises two or four EF-hand motifs, wherein at least one EF-hand motif comprises said deletion in the calcium-binding loop sequence and the other EF-hand motif(s) comprise said deletion or not, and a fluorescence-acceptor protein. 8. The fusion protein of claim 7 , which comprises a sequence selected from the group consisting of SEQ ID NO: 35, 38, 61, 63 and 67. 9. The polypeptide of claim 1 or a fusion protein comprising a polypeptide according to claim 1 fused to another protein moiety, which is immobilized onto a solid support. 10. A polynucleotide encoding the polypeptide of claim 1 . 11. A host cell comprising with the polynucleotide of claim 10 , wherein the host cell is not an organism. 12. A non-human transgenic organism comprising the polynucleotide of claim 10 . 13. A method of detecting uranium contamination in a sample comprising contacting the sample with a uranyl chelating agent comprising: i. the polypeptide of claim 1 , ii. a fusion protein comprising a polypeptide according to claim 1 fused to another protein moiety, iii. a host cell comprising a polynucleotide encoding the polypeptide of claim 1 or a fusion protein comprising a polypeptide according to claim 1 fused to another protein moiety, or iv. A non-human transgenic organism comprising a polynucleotide encoding the polypeptide of claim 1 or a fusion protein comprising a polypeptide according to claim 1 fused to another protein moiety, and detecting the presence of uranyl chelation in the sample. 14. A method of decontaminating or bio-remediating a sample containing uranium comprising contacting the sample with a uranyl chelating agent comprising: i. the polypeptide of claim 1 , ii. a fusion protein comprising a polypeptide according to claim 1 fused to another protein moiety, iii. a host cell comprising a polynucleotide encoding the polypeptide of claim 1 or a fusion protein comprising a polypeptide according to claim 1 fused to another protein moiety, or iv. A non-human transgenic organism comprising a polynucleotide encoding the polypeptide of claim 1 or a fusion protein comprising a polypeptide according to claim 1 fused to another protein moiety. 15. The polypeptide of claim 3 , which consists of an amino acid sequence selected from the group consisting of SEQ ID NO: 17, 18, 20 and 60. 16. The fusion protein of claim 7 , which consists of a sequence selected from the group consisting of SEQ ID NO: 35, 38, 61, 63 and 67. 17. A polynucleotide encoding a fusion protein comprising the polypeptide according to claim 1 fused to another protein moiety.

Assignees

Inventors

Classifications

  • Calcium binding proteins, e.g. calmodulin · CPC title

  • in polymeric matrix, e.g. resins, tars · CPC title

  • containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP] · CPC title

  • Metals · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9845343B2 cover?
Uranium-chelating polypeptides comprising at least one helix-loop-helix calcium-binding (EF-hand) motif which comprises a deletion of at least two amino acid in the 12-amino-acid calcium-binding loop sequence, and their use for uranium biodetection and biodecontamination.
Who is the assignee on this patent?
Commissariat Energie Atomique
What technology area does this patent fall under?
Primary CPC classification C07K14/4728. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).